172 related articles for article (PubMed ID: 20422244)
1. Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma.
Komura K; Inamoto T; Tsuji M; Ibuki N; Koyama K; Ubai T; Azuma H; Katsuoka Y
Int J Clin Oncol; 2010 Dec; 15(6):594-600. PubMed ID: 20422244
[TBL] [Abstract][Full Text] [Related]
2. Adenoid cystic/basal cell carcinoma of the prostate: review and update.
Begnami MD; Quezado M; Pinto P; Linehan WM; Merino M
Arch Pathol Lab Med; 2007 Apr; 131(4):637-40. PubMed ID: 17425398
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Aug; 39(8):721-4. PubMed ID: 24152659
[TBL] [Abstract][Full Text] [Related]
5. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.
McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ; Young RH
Am J Surg Pathol; 2004 Oct; 28(10):1289-98. PubMed ID: 15371944
[TBL] [Abstract][Full Text] [Related]
6. Basaloid carcinoma of the prostate: an extremely rare tumor.
Rodriguez-Carlin A; Arellano L; López-Fontana G; Bolufer E; Castillo OA
Arch Esp Urol; 2013 May; 66(4):380-4. PubMed ID: 23676544
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature.
Chang K; Dai B; Kong Y; Qu Y; Wu J; Ye D; Yao X; Zhang S; Zhang H; Zhu Y; Yao W
World J Surg Oncol; 2013 Aug; 11(1):193. PubMed ID: 23941693
[TBL] [Abstract][Full Text] [Related]
8. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study.
Grignon DJ; Ro JY; Ordoñez NG; Ayala AG; Cleary KR
Hum Pathol; 1988 Dec; 19(12):1425-33. PubMed ID: 2461340
[TBL] [Abstract][Full Text] [Related]
9. Basal cell carcinoma of the prostate: report of a case and review of the published reports.
Segawa N; Tsuji M; Nishida T; Takahara K; Azuma H; Katsuoka Y
Int J Urol; 2008 Jun; 15(6):557-9. PubMed ID: 18489650
[TBL] [Abstract][Full Text] [Related]
10. Basaloid carcinoma of the prostate gland. An unusual finding.
Parada DD; López CA; Moreira O
Arch Esp Urol; 2004 Jun; 57(5):573-8. PubMed ID: 15382579
[TBL] [Abstract][Full Text] [Related]
11. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
Yilmaz M; Celen Z; Sevinc A; Karakok M
Clin Nucl Med; 2009 Sep; 34(9):598-600. PubMed ID: 19692822
[TBL] [Abstract][Full Text] [Related]
12. Focal neuroendocrine differentiation in prostatic gland carcinoma with basaloid pattern.
Gligorijević JV; Velicković LV; Jancić SA; Radovanović Z; Krstić MS; Katić VV
Vojnosanit Pregl; 2011 Jun; 68(6):515-8. PubMed ID: 21818920
[TBL] [Abstract][Full Text] [Related]
13. [Basal cell carcinoma of prostate: a report of three cases].
Liu Z; Ma LL; Zhang SD; Lu M; Tian Y; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):720-724. PubMed ID: 29263520
[TBL] [Abstract][Full Text] [Related]
14. [Small cell carcinoma of the prostate: a case report].
Sasaki M; Kobayashi T; Ono K; Sugano O; Sasao S; Hoshi S
Hinyokika Kiyo; 2006 Sep; 52(9):719-21. PubMed ID: 17040059
[TBL] [Abstract][Full Text] [Related]
15. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
[TBL] [Abstract][Full Text] [Related]
16. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
Zhou M; Shah R; Shen R; Rubin MA
Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
[TBL] [Abstract][Full Text] [Related]
17. Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative.
McEwan LM; Wong D; Yaxley J
J Med Imaging Radiat Oncol; 2017 Aug; 61(4):503-505. PubMed ID: 28349676
[TBL] [Abstract][Full Text] [Related]
18. NKX3.1 expression in cervical 'adenoid basal cell carcinoma': another gynaecological lesion with prostatic differentiation?
Stewart CJR; Moses J
Pathology; 2021 Feb; 53(2):193-198. PubMed ID: 33032811
[TBL] [Abstract][Full Text] [Related]
19. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.
Kang PM; Seo WI; Lee SS; Bae SK; Kwak HS; Min K; Kim W; Kang DI
Asian Pac J Cancer Prev; 2014; 15(20):8699-703. PubMed ID: 25374193
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer with aberrant diffuse p63 expression: report of a case and review of the literature and morphologic mimics.
Wu A; Kunju LP
Arch Pathol Lab Med; 2013 Sep; 137(9):1179-84. PubMed ID: 23991727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
